Terazosin
Product Images NDC 53217-212

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 53217-212). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Terazosin Hydrochloride Chemical Structure (Terazosin Usp 2mg 1)

FDA Label Image

Figure 1 (Terazosin Usp 2mg 2)

FDA Label Image

Figure 2 (Terazosin Usp 2mg 3)

Figure 2 (Terazosin Usp 2mg 3)
This is a data set that charts the mean change from baseline at different timepoints over 30 months, with data points taken at months 0, 1, 2, 3, 6, 9, 12, 15, 18, 21, 24, 27 and 30.*
FDA Label Image

Figure 3 (Terazosin Usp 2mg 4)

FDA Label Image

Image Label (Terazosin Usp 2mg 5)

Image Label (Terazosin Usp 2mg 5)
This is a medication called Terazosin, USP. It comes in the form of ivory oblong capsules with the code TL 384 imprinted on one side. Each capsule contains 2mg of the active ingredient Terazosin hydrochloride. It is commonly known by the brand name Hytrin. It is prescribed for those who suffer from an enlarged prostate or hypertension. This medicine should only be taken with a prescription and should be kept out of reach of children. It should be stored at controlled room temperature. The packaging includes useful information about dosage and the manufacturer details.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.